Detalhe da pesquisa
1.
Reproducible pharmacogenomic profiling of cancer cell line panels.
Nature
; 533(7603): 333-7, 2016 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27193678
2.
Germline genetic polymorphisms influence tumor gene expression and immune cell infiltration.
Proc Natl Acad Sci U S A
; 115(50): E11701-E11710, 2018 12 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30463956
3.
Recurrent R-spondin fusions in colon cancer.
Nature
; 488(7413): 660-4, 2012 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-22895193
4.
Application of Mass Spectrometry Profiling to Establish Brusatol as an Inhibitor of Global Protein Synthesis.
Mol Cell Proteomics
; 15(4): 1220-31, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26711467
5.
The mutation spectrum revealed by paired genome sequences from a lung cancer patient.
Nature
; 465(7297): 473-7, 2010 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-20505728
6.
Diverse somatic mutation patterns and pathway alterations in human cancers.
Nature
; 466(7308): 869-73, 2010 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-20668451
7.
Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agents.
Breast Cancer Res
; 17: 59, 2015 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-25902869
8.
The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients.
Genome Res
; 22(4): 593-601, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22267523
9.
Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events.
Genome Res
; 22(12): 2315-27, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23033341
10.
PAK1 mediates pancreatic cancer cell migration and resistance to MET inhibition.
J Pathol
; 234(4): 502-13, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25074413
11.
Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells.
Proc Natl Acad Sci U S A
; 108(17): 7177-82, 2011 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-21482786
12.
Large-scale integrative network-based analysis identifies common pathways disrupted by copy number alterations across cancers.
BMC Genomics
; 14: 440, 2013 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23822816
13.
Genetic alterations and oncogenic pathways associated with breast cancer subtypes.
Mol Cancer Res
; 7(4): 511-22, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19372580
14.
Super-enhancer acquisition drives oncogene expression in triple negative breast cancer.
PLoS One
; 15(6): e0235343, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32584896
15.
High-resolution genomic and expression analyses of copy number alterations in breast tumors.
Genes Chromosomes Cancer
; 47(6): 530-42, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18335499
16.
Distinguishing cancer-associated missense mutations from common polymorphisms.
Cancer Res
; 67(2): 465-73, 2007 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17234753
17.
Multiple-gene targeting and mismatch tolerance can confound analysis of genome-wide pooled CRISPR screens.
Genome Biol
; 20(1): 21, 2019 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30683138
18.
Transposable element expression in tumors is associated with immune infiltration and increased antigenicity.
Nat Commun
; 10(1): 5228, 2019 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31745090
19.
Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation.
Cell Rep
; 24(7): 1722-1729, 2018 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30110629
20.
A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types.
NPJ Precis Oncol
; 2(1): 7, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29872725